Cart
sales@molnova.com
6-Chloro-7-deazapurine-β-D-riboside
CAS No. 16754-80-6
6-Chloro-7-deazapurine-β-D-riboside( —— )
Catalog No. M28127 CAS No. 16754-80-6
6-Chloro-7-deazapurine-β-D-riboside shows antifungal activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 25MG | 35 | In Stock |
|
| 50MG | 50 | In Stock |
|
| 100MG | 72 | In Stock |
|
| 200MG | 106 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name6-Chloro-7-deazapurine-β-D-riboside
-
NoteResearch use only, not for human use.
-
Brief Description6-Chloro-7-deazapurine-β-D-riboside shows antifungal activity.
-
Description6-Chloro-7-deazapurine-β-D-riboside shows antifungal activity.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetAntibacterial
-
Recptorβ-Lactamase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number16754-80-6
-
Formula Weight285.68
-
Molecular FormulaC11H12ClN3O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (350.04 mM)
-
SMILESOC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n1ccc2c(Cl)ncnc12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.David T Davies, et al. Discovery of ANT3310, a Novel Broad-Spectrum Serine β-Lactamase Inhibitor of the Diazabicyclooctane Class, Which Strongly Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacterales and Acinetobacter baumannii. J Med Chem. 2020 Dec 24;63(24):15802-15820.
molnova catalog
related products
-
M4284
M4284 (M-4284) is a high-affinity biphenyl mannoside FimH inhibitor with HAI of 16 nM in hemagglutination assay.
-
Nacubactam (b)
Nacubactam (OP 0595, RG 6080, RO 7079901) is a diazabicyclooctane that inhibits class A and C β-lactamases with IC50 of <1 uM.
-
Cefodizime
Cefodizime is a new cephalosporin antibiotic with a wide range of biological activities.Cefodizime is non-toxic to the kidneys and is well tolerated with immunomodulatory activity.
